HomeBusinessHealthcareAxogen CEO On The Growth Outlook For The Company
Axogen CEO On The Growth Outlook For The Company

Axogen (AXGN) earnings report indicated -$0.08 in EPS and $31.04M in revenue. The company develops solutions for peripheral nerve regeneration and repair, while helping health care providers restore quality of life to patients. Its CEO, president, and chairman, Karen Zaderej, weighs in on what is next. The AXGN stock is up about 17% in 2021.

The Watch List

13 May 2021

ON AIR
3:30 am
Trading 360
replay
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
ON AIR
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
education
3:30 pm
Your First Trade
4:00 pm
Trading 360
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Your First Trade
REPLAY
7:30 pm
Trading 360
REPLAY
8:30 pm
Fast Market
REPLAY
9:30 pm
Next Gen Investing
REPLAY
education
10:30 pm
Your First Trade
REPLAY
11:00 pm
Trading 360
REPLAY

Get Market Minute

Daily insights for every investor

FOLLOW US